Related Experiment Video
Updated: Nov 19, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19
Hui Liu1,2, Jing Chen3,4, Qin Yang5
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Insights
A new PAWNN score, using complete blood count (CBC) parameters like platelet count and age, accurately predicts COVID-19 patient mortality. This simple tool aids clinicians in prioritizing care for critically ill patients.
Area of Science:
- Hematology
- Infectious Diseases
- Critical Care Medicine
Background:
- Developing accurate prognostic tools for coronavirus disease 2019 (COVID-19) is crucial for patient management.
- Complete blood count (CBC) parameters offer a readily available resource for risk stratification.
Purpose of the Study:
- To develop and validate a sensitive risk score for predicting mortality in COVID-19 patients using CBC parameters.
- To create a simple yet accurate tool to aid clinical decision-making.
Main Methods:
- A retrospective cohort study involving 13,138 COVID-19 inpatients from China and Italy.
- Generalized linear mixed models (GLMM) and Cox regression were used to identify predictors and construct the PAWNN score.
- The score was validated using 10-fold cross-validation and independent cohorts.
Main Results:
- The PAWNN score, incorporating platelet counts, age, white blood cell counts, neutrophil counts, and neutrophil:lymphocyte ratio, demonstrated high accuracy (AUROCs 0.92-0.97) in predicting mortality.
- The score showed consistent performance across different patient subgroups and validation cohorts.
- Latent Markov models confirmed the score's predictive power for disease progression.
Conclusions:
- The PAWNN score is a validated, simple, and accurate tool for assessing COVID-19 patient mortality risk throughout hospitalization.
- This risk assessment tool can assist clinicians in prioritizing treatment for COVID-19 patients, potentially improving outcomes.
Background:
To develop a sensitive risk score predicting the risk of mortality in patients with coronavirus disease 2019 (COVID-19) using complete blood count (CBC).
Methods:
We performed a retrospective cohort study from a total of 13,138 inpatients with COVID-19 in Hubei, China, and Milan, Italy. Among them, 9,810 patients with ≥2 CBC records from Hubei were assigned to the training cohort. CBC parameters were analyzed as potential predictors for all-cause mortality and were selected by the generalized linear mixed model (GLMM).
Findings:
Five risk factors were derived to construct a composite score (PAWNN score) using the Cox regression model, including platelet counts, age, white blood cell counts, neutrophil counts, and neutrophil:lymphocyte ratio. The PAWNN score showed good accuracy for predicting mortality in 10-fold cross-validation (AUROCs 0.92-0.93) and subsets with different quartile intervals of follow-up and preexisting diseases. The performance of the score was further validated in 2,949 patients with only 1 CBC record from the Hubei cohort (AUROC 0.97) and 227 patients from the Italian cohort (AUROC 0.80). The latent Markov model (LMM) demonstrated that the PAWNN score has good prediction power for transition probabilities between different latent conditions.
Conclusions:
The PAWNN score is a simple and accurate risk assessment tool that can predict the mortality for COVID-19 patients during their entire hospitalization. This tool can assist clinicians in prioritizing medical treatment of COVID-19 patients.
Funding:
This work was supported by National Key R&D Program of China (2016YFF0101504, 2016YFF0101505, 2020YFC2004702, 2020YFC0845500), the Key R&D Program of Guangdong Province (2020B1111330003), and the medical flight plan of Wuhan University (TFJH2018006).
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cancer Survival Analysis
Relative Risk

